(Date:12/1/2009)..., , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswi...: PDLI ) today announced revenue guidance for the...mately $57 million, as compared with $69 million f...quarter 2008 results was the first of two installm...included in fourth quarter 2008 results was a one-...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...arch report is available in its catalogue: ,, ...: Market dynamics and the changing healthcare and ...nker.com/p0165658/Emerging-Clinical-Trial-Location...g-healthcare-and-regulatory-environment.html ,...
(Date:12/1/2009)..., , Former Majority Leader Richard Ge...ience, Medicine, Biotech Communities for "Best an...ERSEY CITY, N.J., Dec. 1 /PRNewswire-USNewswire/ -...n biopharmaceuticals, research, medicine and techn... to discuss the importance of medical innovation i...
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2...nited States Senate, by a vote of 63-37, has enact...an on new federal funding for embryonic stem cell ...ntial veto. , ,The measure fell short of the 67 vo...first veto of the Bush presidency. , ,The bill, kn...as enacted without the possibility of amendment, w...
...g the destruction of human embryos a line that soc... a bill that would have overturned his ban on new ...arch, and an override attempt failed in the House ...y that our decent society needs to respect, so I v...irst of his presidency. , ,The measure, known as t...
...eaker than-expected results from automotive units,...otive systems and building controls company, repor...,The annual profit outlook, however, is getting di... automotive interiors. , ,Johnson Controls, sales ... $8.4 billion from $7.1 billion for the 2005 quart...
Other Biology Technology:Senate approves bill to expand stem cell funding 2Bush vetoes stem cell research bill 2Bush vetoes stem cell research bill 3Johnson Controls reports record quarterly sales 2Mouse Anti-Calcium Channel alpha 2 delta-2 Monoclonal Antibody, Unconjugated, Clone 42 from BD Biosciences Pharmingen
Mouse Anti-Neuropilin-2 Monoclonal Antibody, Unconjugated, Clone 54 from BD Biosciences Pharmingen
Dynabeads M-450 Epoxy from Dynal Biotech
Mouse Anti-CBF-B Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.
Biology Products: